CUE BIOPHARMA INC. -

Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference

25 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights

14 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Organizational Transition

14 Nov 2024 07:00:09 By Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

12 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

08 Nov 2024 12:30:00 By Nasdaq GlobeNewswire

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

04 Oct 2024 08:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Announces Pricing of $12.0 Million Public Offering

26 Sep 2024 22:26:30 By Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 Sep 2024 22:10:15 By Nasdaq GlobeNewswire

Cue Biopharma Announces Proposed Public Offering

26 Sep 2024 15:27:02 By Nasdaq GlobeNewswire

Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer

09 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference

03 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

19 Aug 2024 15:05:00 By Nasdaq GlobeNewswire

Cue Biopharma to Host Business Update Call and Webcast

13 Aug 2024 07:00:01 By Nasdaq GlobeNewswire

Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements

25 Jul 2024 15:05:00 By Nasdaq GlobeNewswire

Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting

04 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024

03 Jun 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights

09 May 2024 15:05:01 By Nasdaq GlobeNewswire

Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

08 May 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference

07 May 2024 07:00:00 By Nasdaq GlobeNewswire

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

24 Apr 2024 09:01:00 By Nasdaq GlobeNewswire